It is a pleasure to serve with you in the Chair, Mr Bone. I congratulate my hon. Friend the Member for Ealing, Southall (Mr Sharma) on securing the debate and on his comprehensive introduction. No one wants antibiotics to be used when they are not necessary, whether in animals or humans, and he made his case powerfully.
As I represent Cambridge, it is not surprising that I have been briefed on a number of occasions by clinicians and scientists about the risks of antimicrobial resistance. The issue was brought to my attention soon after I was elected in 2015, long before I took on responsibilities relating to farmed animal health, so I have taken a close interest. I am grateful for excellent briefings from a wide range of organisations, including the Parliamentary Office of Science and Technology, the Alliance to Save Our Antibiotics, the British Veterinary Association, the
National Farmers Union, the National Office of Animal Health, MSD Animal Health, World Animal Protection and Compassion in World Farming, among others. There is considerable interest and expertise.
There is no doubt about it: antimicrobial resistance is a challenge that affects the whole world, with—as we have heard—an estimated 4.95 million people losing their lives because of an antibiotic-resistant infection in 2019. According to research published in The Lancet last November, 1.27 million of those deaths were attributed to the antibiotic resistance of the infection. I suspect that many of us are familiar with the 2014 review, chaired by Jim O’Neill, which warned that annual deaths due to antimicrobial resistance could rise to 10 million by 2050.
Consequently, it comes as no surprise that the World Health Organisation deems antibiotic resistance to be one of the biggest threats to global health, food security and development. I do not think anyone is under any illusion about the scale of the problem that we face, its risk to human health and how important it is that we reduce our use of antibiotics. In recent years, we have rightly seen considerable efforts made to reduce the use of unnecessary antibiotics in both humans and animals.
Since 2014, annual sales of veterinary antibiotics in the UK have reduced by 55%, with the Responsible Use of Medicines in Agriculture Alliance—RUMA—playing an important role. That achievement was commended by the UN Food and Agriculture Organisation in a report published last year, which said:
“The United Kingdom’s example demonstrates that building trusted relationships across all stakeholders, including between farmers, vets, and government, can lead to sustained behaviour change, and embed practices of responsible use across farming sectors. Industry leadership on the issue has empowered producers to take action. Farmers now have open conversations with their peers on the importance of addressing AMR, and the steps which can be taken in their respective areas.”
That reference to industry leadership and building relationships across all stakeholders is critical, as it is for so many areas in the food and farming sectors. There are many tensions within our food system today, some of which are understandably a result of the need to maximise output to feed a growing global population.
As we have rightly better understood the consequences, we are now trying to find a balance between that output and the environmental, health and animal welfare issues that are so important. Although progress has been made, we still face major challenges. For example, the Alliance to Save Our Antibiotics advises that 75% of antibiotics used in UK farms are for group treatments, as my hon. Friend the Member for Ealing, Southall pointed out. That stands in contrast to other countries that manage to use antibiotics only to treat individual sick animals. Sweden and Finland are cited as examples. Although exact comparisons are difficult, we should always aspire to the highest standards here. We also heard in the introduction that some farms still use antibiotics in a routine way when others do not. The fear is that in some cases that is compensating for poor husbandry. Again, we should aim higher.
Let me ask the Minister about the Government’s antimicrobial resistance national action plan in which it was stated, as we have already heard, that the UK would implement legislation along lines similar to those being adopted by the European Union. Is that still
the plan? If so, when? Why are we yet again falling behind the EU? This is the second time in this Chamber today that the Minister will have to explain why the Government have relegated the UK to the slow lane. What assessment has been made of the consequences for British farmers who export to the EU? What can the Minister tell us about ensuring in trade deals that we do not risk importing food produced to lower standards on antibiotic usage?
A key to reducing the use of antibiotics is, of course, vaccination. I am grateful to the National Office of Animal Health, which issued livestock vaccination guidelines last May to help vets and farmers to improve resilience, for its advice. Will the Minister tell us what support the Department is giving to vaccine development?
In conclusion, this is a short debate on a subject that merits much more detailed discussion. Overuse of antibiotics in general, and certainly in farming in the past, has clearly put us at risk from rising antimicrobial resistance. The falling use of antibiotics indicates that we are moving in the right direction, but there is more to do. As we transform and improve our farming systems to address wider environmental and health challenges, I am in no doubt that moving away from antibiotic use will play a key role in improving and safeguarding our health as well as the health of animals stewarded by farmers and vets.
4.56 pm